Loading...
Intra-Articular Syringe Arthrum Visc 75 Mono Injection Hyaluronic Acid 3 Ml
Sold out
€105,68
Unit price
/
Unavailable
Tax included, shipping and discounts calculated at checkout.
ANFATIS | SKU:
972644429
Notify me when it's back in stock!
Write us your email, you will be notified when this product becomes available again!
Intra-Articular Syringe Arthrum Visc 75 Mono Injection Hyaluronic Acid 3 Ml is backordered and will ship as soon as it is back in stock.
Shipping Costs and Times
Shipping Costs and Times
- Order fulfillment within 24 hours and delivery within the following 48/72 hours.
- Shipping cost: always free for orders over €49.90, otherwise it costs €4.99.
Payments
Payments
Payment information is processed securely. We do not store credit card information or have access to your credit card information.
Returns and Refunds
Returns and Refunds
You can return and receive a refund for the item within 30 days. See full policy here.
Do you need help?
Our customer service is here to help you!
- Contact us by phone, email or WhatsApp, from Monday to Friday, from 9:00 to 20:00 .
- For common questions, such as tracking your order or checking its fulfillment status, you can count on our artificial intelligence , available 24/7 .
We are always at your side to offer you fast and effective support!
Description
Description
INTRA-ARTICULAR SYRINGE ARTHRUM VISC 75 MONO INJECTION HYALURONIC ACID 3 ML
ARTHUR 75
Description
Sterile, apyrogenic and physiological viscoelastic solution based on non-cross-linked hyaluronic acid of non-animal origin. The solution is presented in a single-use pre-filled syringe. Each pack contains a syringe of ARTHRUM VISC 75, an information leaflet and a set of labels to ensure traceability.
Indicated to reduce pain and restore joint mobility by replacing and integrating the elastoviscosity of the synovial fluid of the arthritic joint. ARTHRUM VISC 75 exerts its therapeutic effect by viscosupplementation, a process that improves the physiological and rheological properties of the synovial fluid of the arthritic knee. ARTHRUM VISC 75 is indicated for the symptomatic treatment of gonarthrosis by intra-articular injection.
ARTHRUM VISC 75 must be administered exclusively intra-articularly by a physician to relieve pain associated with osteoarthritis of the knee.
How to use
Intended for intra-articular injection by a licensed medical specialist in accordance with applicable local laws.
Technical skill is essential for successful treatment, this medical device must be used by physicians with specific training in injection techniques.
The medical device must be used in its original packaging as supplied.
Any modification or use of the product not in accordance with the conditions of use reported in this leaflet could compromise its sterility, efficacy and tolerance. The doctor must inform the patient of the indications, contraindications, incompatibilities and potential adverse effects of the medical device before starting treatment.
- Before injecting, thoroughly disinfect the area to be treated.
- Check that the sterile protection is intact.
- Take the syringe and remove the protective cap.
- Holding the body of the syringe, insert the needle into the Luer Lock fitting.
- Carefully rotate the needle clockwise to secure it into the socket.
- visually check that the needle is properly secured.
- Remove the needle cap.
- Inject slowly.
Failure to follow these instructions may result in needle disengagement and/or leakage of the medical device at the Luer Lock connection.
The dosage regimen of ARTHRUM VISC 75 involves an intra-articular injection.
Components
Sodium hyaluronate 75 mg.
Warnings
It should not be administered to:
- patients hypersensitive to hyaluronic acid;
- patients with autoimmune diseases, sarcoidosis, severe multiple allergies, cardiovascular diseases;
with intake of anticoagulants;
- patients on immunosuppressants or interferon;
- pregnant or breastfeeding women;
- children.
Do not administer intravascularly.
Do not inject outside the joint cavity, nor into the synovial tissue or capsule.
Hyaluronic acid solution (sodium hyaluronate) is incompatible with quaternary ammonium salts such as benzalkonium chloride.
ARTHRUM VISC 75 must never come into contact with the above products or with surgical material previously cleaned with them.
The physician must inform the patient of the potential immediate or delayed adverse effects related to the administration of this medical device prior to injection.
Potential side effects:
- Immediate side effects related to the injection:
pain, redness, swelling at the injection site.
- Side effects of inflammatory origin:
Pseudogout attack.
Chondrocalcinosis.
Pseudoseptic arthritis.
- Other side effects:
Poor efficacy or poor effect of treatment with respect to a particularly advanced radiological stage of gonarthrosis.
The patient must immediately report the appearance and/or persistence of side effects to the doctor, who will have to remedy them with appropriate treatment.
Any other undesirable side effects related to the administration of the medical device must be reported to the distributor and/or the manufacturer.
- Check the expiration date indicated on the label.
- Do not reuse, sterility cannot be guaranteed.
- Do not resterilize.
- It is recommended to use sterile 21G (0.8 x 50 mm) needles with Luer tips and ensure their compatibility with Luer-Lock fittings before use.
- Used needles and syringes must be disposed of in the appropriate containers in accordance with current regulations.
Conservation
Store away from frost, heat and light.
Validity with intact packaging: 36 months.
Format
3 ml syringe.
Code RVE 111-3100
Sterile, apyrogenic and physiological viscoelastic solution based on non-cross-linked hyaluronic acid of non-animal origin. The solution is presented in a single-use pre-filled syringe. Each pack contains a syringe of ARTHRUM VISC 75, an information leaflet and a set of labels to ensure traceability.
Indicated to reduce pain and restore joint mobility by replacing and integrating the elastoviscosity of the synovial fluid of the arthritic joint. ARTHRUM VISC 75 exerts its therapeutic effect by viscosupplementation, a process that improves the physiological and rheological properties of the synovial fluid of the arthritic knee. ARTHRUM VISC 75 is indicated for the symptomatic treatment of gonarthrosis by intra-articular injection.
ARTHRUM VISC 75 must be administered exclusively intra-articularly by a physician to relieve pain associated with osteoarthritis of the knee.
How to use
Intended for intra-articular injection by a licensed medical specialist in accordance with applicable local laws.
Technical skill is essential for successful treatment, this medical device must be used by physicians with specific training in injection techniques.
The medical device must be used in its original packaging as supplied.
Any modification or use of the product not in accordance with the conditions of use reported in this leaflet could compromise its sterility, efficacy and tolerance. The doctor must inform the patient of the indications, contraindications, incompatibilities and potential adverse effects of the medical device before starting treatment.
- Before injecting, thoroughly disinfect the area to be treated.
- Check that the sterile protection is intact.
- Take the syringe and remove the protective cap.
- Holding the body of the syringe, insert the needle into the Luer Lock fitting.
- Carefully rotate the needle clockwise to secure it into the socket.
- visually check that the needle is properly secured.
- Remove the needle cap.
- Inject slowly.
Failure to follow these instructions may result in needle disengagement and/or leakage of the medical device at the Luer Lock connection.
The dosage regimen of ARTHRUM VISC 75 involves an intra-articular injection.
Components
Sodium hyaluronate 75 mg.
Warnings
It should not be administered to:
- patients hypersensitive to hyaluronic acid;
- patients with autoimmune diseases, sarcoidosis, severe multiple allergies, cardiovascular diseases;
with intake of anticoagulants;
- patients on immunosuppressants or interferon;
- pregnant or breastfeeding women;
- children.
Do not administer intravascularly.
Do not inject outside the joint cavity, nor into the synovial tissue or capsule.
Hyaluronic acid solution (sodium hyaluronate) is incompatible with quaternary ammonium salts such as benzalkonium chloride.
ARTHRUM VISC 75 must never come into contact with the above products or with surgical material previously cleaned with them.
The physician must inform the patient of the potential immediate or delayed adverse effects related to the administration of this medical device prior to injection.
Potential side effects:
- Immediate side effects related to the injection:
pain, redness, swelling at the injection site.
- Side effects of inflammatory origin:
Pseudogout attack.
Chondrocalcinosis.
Pseudoseptic arthritis.
- Other side effects:
Poor efficacy or poor effect of treatment with respect to a particularly advanced radiological stage of gonarthrosis.
The patient must immediately report the appearance and/or persistence of side effects to the doctor, who will have to remedy them with appropriate treatment.
Any other undesirable side effects related to the administration of the medical device must be reported to the distributor and/or the manufacturer.
- Check the expiration date indicated on the label.
- Do not reuse, sterility cannot be guaranteed.
- Do not resterilize.
- It is recommended to use sterile 21G (0.8 x 50 mm) needles with Luer tips and ensure their compatibility with Luer-Lock fittings before use.
- Used needles and syringes must be disposed of in the appropriate containers in accordance with current regulations.
Conservation
Store away from frost, heat and light.
Validity with intact packaging: 36 months.
Format
3 ml syringe.
Code RVE 111-3100